How Covid-19 is still affecting health-care workers - Charlotte Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
/
Charlotte-based Atrium Health is opening a new trial for children ages 12 to 17 that will test a COVID-19 vaccine manufactured by Novavax, the hospital system announced on Friday.
Currently, there is no COVID-19 vaccine authorized in the U.S. for children under the age of 16, though Pfizer is expected to receive emergency federal approval as early as Monday for its vaccine to be administered in people ages 12 to 15.
To enroll in the Novavax trial at Atrium, children must be 12 to 17 years old, not have been previously diagnosed with COVID-19, not be receiving treatment for cancer and not have any medical condition that affects their immune system response. Children who participate in the study will be monitored for two years, during which researchers will perform blood tests and nose swabs to evaluate the vaccine’s effectiveness.
Novant Health Inc. on Monday completed its acquisition of New Hanover Regional Medical Center in Wilmington for a reported $5.3 billion. Courtesy of New Hanover Regional Medical Center
Novant Health Inc. completed Monday its $5.3 billion acquisition of New Hanover Regional Medical Center, establishing a third major operational hub in North Carolina.
The announcement comes 11 days after Josh Stein, the state s attorney general, said he would not object to the deal â the final anti-trust regulatory approval required.
Novant received final approval Oct. 5 by a 4-1 New Hanover Board of Commissioners vote to acquire the 59-year-old health-care system through an asset purchase. Throughout this process, Novant Health has been confident in the tremendous benefits this partnership would bring to the community, Carl Armato, Novant s chief executive and president, said in a statement.